Palantir’s stock can hit $90, says the only analyst whose price target implies upside
But now there is one analyst who’s again projecting upside: Wedbush’s Daniel Ives boosted his target price to $90 on Thursday morning. Palantir’s stock PLTR closed at $76.87 on Wednesday, so his target implies it can rise 17% from there,
Dan Ives, Wedbush, joins 'Fast Money' to talk the U.S.' infrastructure investment plans and what it means for Big Tech.
Wedbush analyst Daniel Ives maintained a Buy rating on Oklo Inc (OKLO – Research Report) today and set a price target of $45.00. The company’s ...
Palantir's AI dominance gains momentum as Wedbush boosts its price target, citing government tailwinds and enterprise ...
Zentalis Pharmaceuticals Inc (ZNTL) stock saw a modest uptick, ending the day at $2.3 which represents a slight increase of $0.04 or 1.77% from the prior close of $2.26. The stock opened at $2.25 and ...
2d
Wedbush Securities hiked its base case price target on Tesla (NASDAQ:TSLA) to $550 from $515 on its view that the golden age ...
Investing.com -- Wedbush upgraded PulteGroup Inc (NYSE:PHM) to "outperform" from "neutral" given an overdone stock price decline and strong catalysts for growth. Shares were up 2.1% at $110.
Wedbush Securities analysts predicted about 20% of the world’s population will access AI through an Apple device over the coming years.
Netflix is set to report fourth-quarter results after the closing bell on Tuesday, with Wall Street analysts holding mostly ...
Healthcare Realty Trust Inc (HR) stock saw a decline, ending the day at $16.47 which represents a decrease of $-0.44 or -2.60% from the prior close of $16.91. The stock opened at $16.82 and touched a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback